Photoredox catalysis harvesting multiple photon or electrochemical energies
Photoredox catalysis (PRC) is a cutting-edge frontier for single electron-transfer (SET)
reactions, enabling the generation of reactive intermediates for both oxidative and reductive …
reactions, enabling the generation of reactive intermediates for both oxidative and reductive …
5-hydroxytryptamine (5-HT) receptor ligands
SL Kitson - Current pharmaceutical design, 2007 - ingentaconnect.com
Serotonin (5-HT) receptors are part of the G protein-coupled and ligand-gated ion channel
families. 5-HT exerts its diverse actions by binding to cell surface receptors which can be …
families. 5-HT exerts its diverse actions by binding to cell surface receptors which can be …
Electrophotochemical Ring-Opening Bromination of tert-Cycloalkanols
K Yamamoto, H Toguchi, M Kuriyama… - The Journal of …, 2021 - ACS Publications
An electrophotochemical ring-opening bromination of unstrained tert-cycloalkanols has
been developed. This electrophotochemical method enables the oxidative transformation of …
been developed. This electrophotochemical method enables the oxidative transformation of …
Antidepressant-like effect of a selenopropargylic benzamide in mice: involvement of the serotonergic system
EM Besckow, NT Nonemacher, CS Garcia… - …, 2020 - Springer
Rationale Major depressive disorder is a psychiatric disorder that requires considerable
attention, since it dramatically impairs the quality of life of the sufferers. The available …
attention, since it dramatically impairs the quality of life of the sufferers. The available …
Luminally released serotonin stimulates colonic motility and accelerates colonic transit in rats
K Tsukamoto, H Ariga, C Mantyh… - American Journal …, 2007 - journals.physiology.org
Enterochromaffin (EC) cells of the epithelial cells release 5-HT into the lumen, as well as
basolateral border. However, the physiological role of released 5-HT into the lumen is poorly …
basolateral border. However, the physiological role of released 5-HT into the lumen is poorly …
Crystallization and Polymorphism under Nanoconfinement
Crystallization outcomes, polymorph stability rankings, and phase transformation pathways
can be significantly altered when crystallization is restricted to dimensions below 1 μm. In …
can be significantly altered when crystallization is restricted to dimensions below 1 μm. In …
5-Hydroxytryptophan activates colonic myenteric neurons and propulsive motor function through 5-HT4 receptors in conscious mice
L Wang, V Martínez, H Kimura… - American Journal of …, 2007 - journals.physiology.org
Serotonin [5-hydroxytryptamine (5-HT)] acts as a modulator of colonic motility and secretion.
We characterized the action of the 5-HT precursor 5-hydroxytryptophan (5-HTP) on colonic …
We characterized the action of the 5-HT precursor 5-hydroxytryptophan (5-HTP) on colonic …
A Sphingolipid Inhibitor Induces a Cytokinesis Arrest and Blocks Stage Differentiation in Giardia lamblia
S Sonda, S Štefanić, AB Hehl - Antimicrobial agents and …, 2008 - Am Soc Microbiol
Sphingolipid biosynthesis pathways have recently emerged as a promising target for
therapeutic intervention against pathogens, including parasites. A key step in the synthesis …
therapeutic intervention against pathogens, including parasites. A key step in the synthesis …
Synthesis and in vitro characterization of trans-and cis-[18F]-4-methylbenzyl 4-[(pyrimidin-2-ylamino) methyl]-3-fluoropiperidine-1-carboxylates as new potential PET …
R Koudih, G Gilbert, M Dhilly, A Abbas, L Barré… - European journal of …, 2012 - Elsevier
Diastereoisomeric compounds [18F] cis-and [18F] trans-4-methylbenzyl 4-[(pyrimidin-2-
ylamino) methyl]-3-fluoro-piperidine-1-carboxylates were successfully synthesized as new …
ylamino) methyl]-3-fluoro-piperidine-1-carboxylates were successfully synthesized as new …
Pharmacological and computational analysis of the involvement of the 5-HT4 receptor in the antidepressant-like effect of N-(3-(phenylselanyl) prop-2-yn-1-yl) …
EM Besckow, CS Pires, MR Giehl, B Godoi… - Brain Research, 2024 - Elsevier
Abstract The serotonin type 4 receptor (5-HT 4 R) shows promise as a target for treating
major depressive disorder (MDD). Studies have demonstrated that 5-HT 4 R agonists have a …
major depressive disorder (MDD). Studies have demonstrated that 5-HT 4 R agonists have a …